Changes in prostaglandin E2 in patients with idiopathic overactive bladder syndrome after botulinum toxin type A treatment: is there a clinical benefit?
Crossref DOI link: https://doi.org/10.1186/1471-2490-14-85
Published Online: 2014-11-04
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hegele, Axel
Knippschild, Sonja
Frohme, Carsten
Hänze, Jörg
Olbert, Peter
Hofmann, Rainer
License valid from 2014-11-04
Article History
Received: 7 July 2014
Accepted: 23 October 2014
First Online: 4 November 2014